Spring Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 17 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 11-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 4.28%
(FY 2022)
- Total Assets -5.72%
(FY 2022)
About Spring Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Amrita Kumari, Yogesh Kumar, and Ashutosh Kumar serve as directors at the Company.
- CIN/LLPIN
U24232DL2007PTC171451
- Company No.
171451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spring Biochem Private Limited offer?
Spring Biochem Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Scale Inhibitor, Thickening Agent, Labelling Machines, Automatic Sticker Labelling Machine, Disinfection Equipment & Machines, Fumigation Machine, Soaps, Detergent Powder & Cakes, Dishwashing Detergents, Water Treatment Chemicals.
Who are the key members and board of directors at Spring Biochem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrita Kumari  | Director | 02-May-2018 | Current |
| Yogesh Kumar | Director | 18-Apr-2023 | Current |
| Ashutosh Kumar | Director | 14-Dec-2007 | Current |
Financial Performance of Spring Biochem.
Spring Biochem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 4.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spring Biochem?
In 2018, Spring Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 30 Oct 2024 | ₹0.50 M | Open |
How Many Employees Work at Spring Biochem?
Unlock and access historical data on people associated with Spring Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spring Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spring Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
